Respiratorius AB
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-634,388.11Net Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.
Show More
CEO
Mr. Johan Drott Ph.D.
Country
Sweden
ISIN
SE0004550192
WKN
000A40WEB
Listings
0 Comments
Share your thoughts
FAQs
What is Respiratorius AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Respiratorius AB stocks are traded under the ticker HF0.STU.
What is Respiratorius AB revenue for the last year?▼
Respiratorius AB revenue for the last year amounts to 0 EUR.
What is Respiratorius AB net income for the last year?▼
HF0.STU net income for the last year is -634,388.11 EUR.
In which sector is Respiratorius AB located?▼
Respiratorius AB operates in the Other sector.
When did Respiratorius AB complete a stock split?▼
The last stock split for Respiratorius AB was on November 27, 2024 with a ratio of 1:100.
Where is Respiratorius AB headquartered?▼
Respiratorius AB is headquartered in Lund, Sweden.